Synergistic effect of N3a with HSPs and mTOR inhibitors in lymphoma cells: Summary of the therapeutic scheme followed in our study, with major findings highlighted in bold
Synergistic effect of N3a with HSPs and mTOR inhibitors in lymphoma cells: Summary of the therapeutic scheme followed in our study, with major findings highlighted in bold. Color-coded arrows represent regulation (red: up-, green: down-). The signaling pathways in which PI3K, mTOR, MDM2, p53, and Hsp90 are participating, are in a continue balance of inter- and intra-activation and deactivation towards cellular homeostasis and fitness. Every imbalance in their regulation supports lymphomagenesis, therefore are targets of promising therapeutic strategies. In the present study we use synergistically four inhibitors of these proteins, namely LY294002, Rapa, N3a, 17-AGG, respectively, aiming to suppress lymphoma cell growth
Publication
Interruption of p53-MDM2 Interaction by Nutlin-3a in Human Lymphoma Cell Models Initiates a Cell-Dependent Global Effect on Transcriptome and Proteome Level (2023) Konstantina Psatha, et al. Cancers (Basel). 2023 Aug;15(15). Figure: F8.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | FKBP12 | FKBP12 | ncbigene_synonym | FKBP1A | 2280 |
| Homo sapiens | Primates | FKBP12 | FKBP12 | ncbigene_synonym | FKBP1AP1 | 2282 |
| Homo sapiens | Primates | FKBP12 | FKBP12 | ncbigene_synonym | FKBP1AP2 | 2283 |
| Homo sapiens | Primates | FKBP12 | FKBP12 | ncbigene_synonym | FKBP1AP3 | 2284 |
| Homo sapiens | Primates | FKBP12 | FKBP12 | ncbigene_synonym | FKBP1AP4 | 2285 |
| Homo sapiens | Primates | mTOR | MTOR | ncbigene_symbol | MTOR | 2475 |
| Homo sapiens | Primates | HSPs | HSP | ncbigene_synonym | HSP90B2P | 7190 |
| Homo sapiens | Primates | MDM2 | MDM2 | ncbigene_symbol | MDM2 | 4193 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R2 | 5296 |
| Homo sapiens | Primates | p53 | P53 | ncbigene_synonym | TP53 | 7157 |
| Homo sapiens | Primates | p53 | P53 | famplex_relations | TP63 | 8626 |
| Homo sapiens | Primates | p53 | P53 | famplex_relations | TP73 | 7161 |
| Homo sapiens | Primates | HSP90 | HSP90 | ncbigene_synonym | HSP90AA1 | 3320 |
| Homo sapiens | Primates | HSP90 | HSP90 | famplex_relations | HSP90B1 | 7184 |
| Homo sapiens | Primates | HSP90 | HSP90 | famplex_relations | TRAP1 | 10131 |
| Homo sapiens | Primates | HSP90 | HSP90 | famplex_relations | HSP90AB1 | 3326 |
| Homo sapiens | Primates | nM | NM | ncbigene_symbol | NM | 4827 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Rapamycin | rapamycin | (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone | chebi:9168 | |
| 17-AAG | 17-AAG | (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate | chebi:64153 | |
| Rapamycin | rapamycin | (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone | chebi:9168 | |
| 17-AAG | 17-AAG | (4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate | chebi:64153 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|